Related Experiment Videos
Antiarrhythmic therapy and survival following myocardial infarction
J C Cowan1, D S Coulshed, A G Zaman
1Department of Cardiovascular Studies, University of Leeds, England.
Insights
Antiarrhythmic drugs are ineffective for preventing sudden cardiac death after myocardial infarction and can increase mortality. Hemodynamic interventions show promise for preventing arrhythmias by influencing myocardial stretch and remodeling.
Area of Science:
- Cardiology
- Electrophysiology
- Pharmacology
Background:
- Arrhythmias are a significant cause of mortality post-myocardial infarction, often stemming from infarct fibrosis and slow conduction.
- While antiarrhythmic drugs benefit select patients with existing arrhythmias, population-wide use has shown detrimental effects, as evidenced by the Cardiac Arrhythmia Suppression Trial (CAST).
Purpose of the Study:
- To evaluate the efficacy of antiarrhythmic drug therapy versus hemodynamic intervention in preventing arrhythmias after myocardial infarction.
- To explore the potential of hemodynamic intervention as a novel strategy for arrhythmia prevention.
Main Methods:
- Review of existing literature on antiarrhythmic drug therapy and its outcomes post-myocardial infarction.
- Analysis of the impact of hemodynamic changes on electrophysiological parameters and arrhythmogenesis.
- Consideration of mechanisms such as myocardial stretch and ventricular remodeling in the context of hemodynamic intervention.
Main Results:
- Antiarrhythmic drug therapy, when applied broadly, has proven ineffective and increases mortality in post-myocardial infarction patients.
- Hemodynamic interventions offer a promising alternative by potentially modulating factors contributing to arrhythmia development.
Conclusions:
- The broad application of antiarrhythmic drugs for arrhythmia prevention post-myocardial infarction is fundamentally flawed.
- Hemodynamic intervention presents a promising new strategy for preventing arrhythmias by targeting underlying physiological changes.
- Further research into hemodynamic interventions is warranted for improved patient outcomes after myocardial infarction.
Abstract:
Arrhythmias remain a major cause of late mortality following myocardial infarction. They arise due to fibrosis within the infarct, which creates the conditions of slow conduction necessary for re-entry. In individual patients who have already manifested a malignant arrhythmia, antiarrhythmic drug therapy, guided by invasive electrophysiological testing, is of proven benefit in prolonging survival. By contrast, when used on a population basis, antiarrhythmic drug therapy has proved singularly ineffective. This is illustrated by the recent Cardiac Arrhythmia Suppression Trial (CAST) study--far from improving survival, antiarrhythmic therapy increased mortality. The use of antiarrhythmic drugs on a population basis is therefore fundamentally flawed. Hemodynamic intervention provides an alternative strategy in arrhythmia prevention. Hemodynamic changes may influence electrophysiological parameters and arrhythmogenesis in a number of ways. First, myocardial stretch may contribute to arrhythmogenesis through contraction-excitation feedback. Second, hemodynamic changes can influence ventricular remodeling following infarction, which may be an important determinant of subsequent arrhythmogenesis. Hemodynamic intervention, therefore, represents a promising new approach to arrhythmia prevention following myocardial infarction.